Examining Cannabis Stocks Earnings: CGC, CRON, MSOS
Schwab Network
English - August 06, 2021 19:45 - 7 minutes - 40.3 MB - ★★★★★ - 23 ratingsNews Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: DigitalOcean (DOCN) Company Overview: Revenue Up 35% Y/Y
Next Episode: Overlooked Stocks: CVNA, ZNGA, DBX
Alan Brochstein, Managing Partner at New Cannabis Ventures and Principal at 420 Investor, examines cannabis stocks. He discusses what investors have learned from Canopy Growth’s (CGC) earnings. He talks about Cronos’ (CRON) 2Q revenue which came in at $15.60M versus an estimated $18.08M. He also mentions AdvisorShares Trust Pure US Cannabis ETF (MSOS). Tune in to find out more.